iSpecimen Inc. (ISPC)
iSpecimen Statistics
Share Statistics
iSpecimen has 2.5M shares outstanding. The number of shares has increased by -92.64% in one year.
| Shares Outstanding | 2.5M |
| Shares Change (YoY) | -92.64% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 3.5% |
| Shares Floating | 2.14M |
| Failed to Deliver (FTD) Shares | 310 |
| FTD / Avg. Volume | 0.06% |
Short Selling Information
The latest short interest is 34.88K, so 3.62% of the outstanding shares have been sold short.
| Short Interest | 34.88K |
| Short % of Shares Out | 3.62% |
| Short % of Float | 3.92% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.15 and the forward PE ratio is null. iSpecimen's PEG ratio is 0.
| PE Ratio | -0.15 |
| Forward PE | n/a |
| PS Ratio | 0.2 |
| Forward PS | 0.1 |
| PB Ratio | 0.57 |
| P/FCF Ratio | -0.23 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for iSpecimen.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.62, with a Debt / Equity ratio of 0.09.
| Current Ratio | 0.62 |
| Quick Ratio | 0.62 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.04 |
| Interest Coverage | -57.84 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $387.13K |
| Profits Per Employee | $-520.74K |
| Employee Count | 24 |
| Asset Turnover | 0.99 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -82.5% in the last 52 weeks. The beta is 1.77, so iSpecimen's price volatility has been higher than the market average.
| Beta | 1.77 |
| 52-Week Price Change | -82.5% |
| 50-Day Moving Average | 1.48 |
| 200-Day Moving Average | 3.67 |
| Relative Strength Index (RSI) | 43.77 |
| Average Volume (20 Days) | 542.21K |
Income Statement
In the last 12 months, iSpecimen had revenue of 9.29M and earned -12.5M in profits. Earnings per share was -17.58.
| Revenue | 9.29M |
| Gross Profit | 3.99M |
| Operating Income | -12.73M |
| Net Income | -12.5M |
| EBITDA | -12.73M |
| EBIT | -12.67M |
| Earnings Per Share (EPS) | -17.58 |
Balance Sheet
The company has 1.88M in cash and 312.17K in debt, giving a net cash position of 1.57M.
| Cash & Cash Equivalents | 1.88M |
| Total Debt | 312.17K |
| Net Cash | 1.57M |
| Retained Earnings | -71.86M |
| Total Assets | 9.35M |
| Working Capital | -2.18M |
Cash Flow
In the last 12 months, operating cash flow was -8.26M and capital expenditures -31.55K, giving a free cash flow of -8.3M.
| Operating Cash Flow | -8.26M |
| Capital Expenditures | -31.55K |
| Free Cash Flow | -8.3M |
| FCF Per Share | -11.67 |
Margins
Gross margin is 42.93%, with operating and profit margins of -136.99% and -134.51%.
| Gross Margin | 42.93% |
| Operating Margin | -136.99% |
| Pretax Margin | -134.51% |
| Profit Margin | -134.51% |
| EBITDA Margin | -136.99% |
| EBIT Margin | -136.99% |
| FCF Margin | -89.28% |
Dividends & Yields
ISPC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ISPC.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Sep 16, 2024. It was a backward split with a ratio of 1:20.
| Last Split Date | Sep 16, 2024 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -14.07 |
| Piotroski F-Score | 3 |